
Strategic Intent: Rubedo’s Seno-Adaptive Bet On Longevity Medicine
Sep 21, 2026 - 40:09
Radio and PodcastLive Radio & Podcasts
Cancer Research UK is best known for funding science. But its commercial arm, Cancer Research Horizons, does something less obvious: it builds companies. This episode features Phil Masterson and Neil Jones, who run its v...